OPATHY - From Omics to Patient: Improving Diagnostics of Pathogenic Yeasts

OPATHY is an innovative translational research training network composed of nine partners from seven European countries. The aim is to explore the potential of next-generation high-throughput technologies, including genomics, transcriptomics and proteomics, to study the interactions of yeasts that cause disease to humans (e.g. Candida and Cryptococcus sp.) with their host. In addition, new diagnostic tools to monitor yeast infections in the clinic will be developed.

OPATHY received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 642095.